Cite Filings / PBLS / 0001346824-26-000178

Feed Companies Filings Check

Sign in

SCHEDULE 13D

Beneficial Ownership Report

Parabilis Medicines, Inc. Filed 2026-06-18 Acc 0001346824-26-000178

Documents 1

SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X02/primary_doc.xml

Around this filing

2026-06-18 SCHEDULE 13D Beneficial Ownership Report
2026-06-16 4 Director bought 17,500 shares at an average $27.06 ($473,529)
2026-06-15 4 Director bought 21,188,750 shares at $20.00 ($423,775,000)
2026-06-15 4 Director acquired 14,688 shares (conversion)
2026-06-15 4 Director bought 12,500 shares at $20.00 ($250,000)
2026-06-15 4 Director acquired 105,414 shares (conversion)
2026-06-11 4 10% owner acquired 1,880,704 shares (conversion)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…